Healthcare & Life Sciences
Deep Apple Therapeutics
United States
aliveseries-c-plus
series-c-plus
Stage
1
Investors
About
Deep Apple Therapeutics uses structure-based virtual screening of ultra-large chemical libraries combined with deep learning to accelerate discovery of small-molecule oral therapeutics, with a focus on cardiometabolic diseases in collaboration with Novo Nordisk.
Explore Deep Apple Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.